Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 3,359 | 1,344 | 2,694 | 1,363 | 2,168 |
| Cost of Goods | 2,060 | 811 | 1,771 | 543 | 1,576 |
| Gross Profit | 1,299 | 533 | 923 | 821 | 591 |
| Operating Expenses | 2,507 | 3,354 | 4,331 | 4,016 | 3,026 |
| Operating Income | -1,148 | -2,010 | -2,637 | -2,653 | -1,858 |
| Interest Expense | 98 | 90 | 90 | 106 | 83 |
| Other Income | 1,525 | -1,239 | 383 | 176 | 254 |
| Pre-tax Income | 280 | -3,340 | -2,344 | -2,584 | -1,688 |
| Net Income Continuous | 280 | -2,664 | -2,344 | -2,584 | -1,688 |
| Net Income | $280 | $-2,664 | $-2,344 | $-2,584 | $-1,688 |
| EBITDA(a) | $-863 | $-1,695 | $-2,226 | $-2,426 | $-1,555 |